A Randomized, Double-Blinded, Double-Dummy, Active-Comparator Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC Compared to Rituximab in Adult Patients with Moderate or Severe Pemphigus (Vulgaris or Foliaceus)
|Effective start/end date||8/19/20 → 8/30/25|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.